Drug intelligence / Profile preview

VRP-1016

Development stage: Preclinical
Lead developer: Venus Medicine Research Centre
Administration: Oral

Overview

VRP-1016 is a preclinical-stage herbal blend developed by the Venus Medicine Research Centre (VMRC), the research and development arm of Venus Remedies. It is categorized as a natural product candidate within the company's pipeline. While the formulation and development (F&D) phase has been completed, the asset is currently undergoing preclinical evaluation. The specific botanical ingredients, molecular targets, and therapeutic indications for VRP-1016 remain undisclosed by the developer, as it is part of a broader series of natural product programs including VRP-1023, VRP-1020, and VRP-1024.

Beyond the preview

Go deeper on VRP-1016.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on VRP-1016.

Explore the full profile